CERTAIN CONFIDENTIAL INFORMATION, MARKED BY [***] HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. ROYALTY PURCHASE AGREEMENT ESPERION THERAPEUTICS, INC. as...Royalty Purchase Agreement • August 12th, 2024 • Esperion Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 12th, 2024 Company Industry JurisdictionAND WHEREAS Seller desires to sell, transfer, assign and convey to Purchaser, and Purchaser desires to purchase, acquire and accept from Seller, Seller’s right, title and interest in and to the Purchased Receivables, upon and subject to the terms and conditions set forth in this Agreement;
CERTAIN CONFIDENTIAL INFORMATION (MARKED BY BRACKETS AS “[***] HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED ROYALTY PURCHASE AGREEMENT (MONJUVI®/MINJUVI®) XENCOR,...Royalty Purchase Agreement • November 7th, 2023 • Xencor Inc • Pharmaceutical preparations • New York
Contract Type FiledNovember 7th, 2023 Company Industry Jurisdiction
CERTAIN CONFIDENTIAL INFORMATION (MARKED BY BRACKETS AS “[***] HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED ROYALTY PURCHASE AGREEMENT XENCOR, INC. as Seller -...Royalty Purchase Agreement • November 7th, 2023 • Xencor Inc • Pharmaceutical preparations • New York
Contract Type FiledNovember 7th, 2023 Company Industry Jurisdiction